CLINICAL AND LABORATORY FEATURES OF THE BLOOD COAGULATION SYSTEM IN PATIENTS WITH CIRRHOSIS OF THE LIVER ASSOCIATED WITH VIRAL HEPATITIS B, C AND D

Abstract

Viral hepatitis is one of the most urgent problems of modern medicine and healthcare. According to WHO, more than 50 million people are infected with viral hepatitis every year [2, 6]. Of these, more than 10% develop chronic viral hepatitis (HCV). In 20% of cases, the outcome of HCV is cirrhosis, and in 5% - hepatocellular carcinoma (HCC) of the liver, which determines high levels of mortality and mortality [1, 2, 6]. Viral liver cirrhosis (CP) is one of the final stages of the morphogenesis of chronic viral hepatitis.